NCT06728449

Brief Summary

After taking written informed consent patients, the selected participants were divided into control and experimental group randomly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
330

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2021

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 6, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

4 months

First QC Date

December 6, 2024

Last Update Submit

December 11, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Waist Circumference

    Normal range of waist circumference in men should be less than 40 inches and in women it should be less than 35 inches. Change in the waist circumference will be monitored during the trial. \>102 cm ( \>40 in ) \>88 cm ( \>35 in )

    60 days

  • Serum Triglyceride Level

    Change in serum Triglyceride Level were monitored before and after the trial

    60 days

  • Serum HDL- Cholesterol Level

    Change in Levels were monitored before and after the trial

    60 days

  • Blood Pressure (Systolic and Diastolic)

    Change in readings were monitored before and after the trial

    60 days

  • Fasting Glucose Level

    Change in readings were monitored before and after the trial

    60 days

Study Arms (5)

Conventional therapy group

ACTIVE COMPARATOR

Control group on Carbohydrate Controlled Diet with conventional therapy

Dietary Supplement: Conventional therapy

Cumin tea group

EXPERIMENTAL

Intervention with Carbohydrate Controlled Diet along with Cumin Seeds Tea

Dietary Supplement: Cumin tea

Ginger Tea Group

EXPERIMENTAL

Intervention with Carbohydrate Controlled Diet along with Ginger Tea

Dietary Supplement: Ginger Tea

Lemon Peel Tea Group

EXPERIMENTAL

Intervention with Carbohydrate Controlled Diet along with Lemon Peel Tea

Dietary Supplement: Lemon Peel Tea

Functional tea Group

EXPERIMENTAL

: Intervention with Carbohydrate Controlled Diet along with Functional Tea

Dietary Supplement: Functional Tea

Interventions

Cumin teaDIETARY_SUPPLEMENT

The preparation involved boiling 200 ml of water with 2 grams of cumin seeds. Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.

Cumin tea group
Ginger TeaDIETARY_SUPPLEMENT

The preparation involved boiling 200 ml of water with 2 grams of ginger. Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.

Ginger Tea Group
Lemon Peel TeaDIETARY_SUPPLEMENT

The preparation involved boiling 200 ml of water with 2 grams of lemon peel. Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.

Lemon Peel Tea Group
Functional TeaDIETARY_SUPPLEMENT

The preparation involved boiling 200 ml of water with 2 grams of functional tisane (0.6 g cumin seeds, 0.6 g ginger, and 0.6 g lemon peel) Patients were instructed to consume/ have tea twice a day i.e. in mid-morning and in the evening without sugar respectively.

Functional tea Group
Conventional therapyDIETARY_SUPPLEMENT

A carbohydrate-controlled diet focuses on limiting refined carbohydrates and sugars and total carbohydrate restriction to 50-70gm per major meal.

Conventional therapy group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Metabolic syndrome patients either gender of 18 to 60 years will be included.
  • Patients will be recruited on the basis of ATP III criteria
  • Patients having any body mass index with confirmed diagnosis of Metabolic Syndrome and no use of any dietary supplement or no adherence to special diets at least one month prior to baseline

You may not qualify if:

  • Individuals with the following conditions will not be included as participants
  • Genetically obese individuals
  • Patients already on lipid lower drugs according to recommendation of physicians
  • Patients taking any nutritional supplement
  • Allergy to any drugs or specific foods
  • Breastfeeding mothers
  • Pregnant females
  • Patients with any other medical history (renal diseases, infections, liver disorders, cardiovascular diseases)
  • Patients receiving weight loss drugs or supplements, receiving any changes in diet or daily exercise programs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Lahore Teaching Hospital

Lahore, Punjab Province, 54000, Pakistan

Location

Related Publications (1)

  • Taghizadeh M, Memarzadeh MR, Abedi F, Sharifi N, Karamali F, Fakhrieh Kashan Z, Asemi Z. The Effect of Cumin cyminum L. Plus Lime Administration on Weight Loss and Metabolic Status in Overweight Subjects: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Iran Red Crescent Med J. 2016 May 23;18(8):e34212. doi: 10.5812/ircmj.34212. eCollection 2016 Aug.

    PMID: 27781121BACKGROUND

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Maria Aslam

    University of Lahore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Double- Blinded
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: After the approval from the relevant authorities from The University of Lahore and Hospital, individuals meeting the ATP III criteria for metabolic syndrome (n = 330) will be selected for inclusion after taking consent. The selected participants will be randomly divided into control and 4 experimental groups. Anthropometric measurements, socio-economic status, nutrient intake and biochemical tests as fasting blood sugar level, triglyceride and cholesterol levels will be taken at beginning (0 day) and 60 days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Maria Aslam

Study Record Dates

First Submitted

December 6, 2024

First Posted

December 11, 2024

Study Start

March 7, 2021

Primary Completion

July 11, 2021

Study Completion

November 20, 2021

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Data will be shared in the form of research articles without the personal information of the participant

Locations